Select Publications
Conference Papers
2019, 'In Vivo Assessment of Intracellular Dynamics Comparing Injection Versus Oral Azacitidine in a Phase IIb Investigator Initiated Clinical Trial', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-123921
,2017, 'Pyrraline, Argpyrimidine and carboxymethyllysine adducts of advanced glycated apoA-IV do not change the apolipoprotein ability in removing cell cholesterol and inhibiting inflammation in macrophages', in MOLECULAR & CELLULAR PROTEOMICS, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, pp. S26 - S26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407623600029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Tryptophan metabolome signature differences in inflammatory bowel diseases', in Gastroenterology, Chicago USA, pp. S840 - S840, presented at Digestive Diseases Week, Chicago USA
,2005, 'A sensitive and selective method for quantification of natural folates in foods using electrospray tandem MS', in Proceedings of the Nutrition Society of Australia, National Society of Australia (NSA), Australia, presented at Nutrition Society of Australia (2005), Melbourne, 30 November 2005 - 03 December 2005
,2005, 'Dolichol is the major lipid component of neuromelanin in human substanta nigra', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 107 - 107, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005
,2005, 'Investigations of the lipid component of neuromelanin', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 58 - 58, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005
,2005, 'Identification of the major lipid component of neuromelanin in human dopamine neurons', in Proceedings of Aust Neuroscience Society, Perth, WA, pp. 139 - 139, presented at 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, 30 January 2005 - 02 February 2005
,1999, 'Reduced animal use in efficacy testing in disease models with use of sequential experimental designs', in Balls M; VanZeller AM; Halder ME (eds.), PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL EXPERIMENTATION, ELSEVIER SCIENCE BV, ITALY, BOLOGNA, pp. 737 - 745, presented at 3rd World Congress on Alternatives and Animal Use in the Life Science, ITALY, BOLOGNA, 29 August 1999 - 02 September 1999, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000169797500069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,